Course Information
15th Annual HIV CME Symposium: Tough Decisions Made Easier

The California Endowment
Los Angeles, CA

Registration is sold out
October 20, 2017

Download: [ PDF ]

Course Description

This one-day symposium is designed to provide participants with relevant, reliable, up-to-date information on the clinical management of HIV-infected patients who have failed one or more antiretroviral regimens, or who have demonstrated some degree of resistance to one or more antiretroviral drugs or classes of drugs. 

Registration Information

By Phone

Registration is sold out. Please call 310-794-2620 to be placed on the waiting list.

Registration Fee

  • $45.00*

*Financial assistance available for qualifying non-profit organizations please contact the program coordinator directly (310) 825-6413 or via email at caresymposium@mednet.ucla.edu 

Refunds

Due to the low enrollment fee, no refunds will be given for this conference. A full refund will be provided if for any reason the course must be cancelled or rescheduled. 

For Further Information

If you have questions about this program, please contact the Program Coordinator at (310) 825-6413 or via email at caresymposium@mednet.ucla.edu. For other UCLA CME offerings visit our website, www.cme.ucla.edu or contact the Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, at 310-794-2620 

Faculty

Program Chairs

Ronald T. Mitsuyasu, MD
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Center for Clinical AIDS
Research and Education 
Los Angeles, CA 

Judith S. Currier, MD
Professor of Medicine
David Geffen School of Medicine at UCLA
Associate Director, Center for Clinical AIDS
Research and Education
Los Angeles, CA 

 

Symposium Faculty

Kara Chew, MD, MS
Assistant Clinical
Professor of Medicine
Division of Infectious Diseases
UCLA CARE Center
David Geffen School of Medicine at UCLA
Los Angeles, CA 

Eric S. Daar, MD
Professor of Medicine
Interim Chair, Department of Medicine
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
David Geffen School of Medicine at UCLA
Los Angeles, CA 

Steven Deeks, MD
Professor of Medicine
University of California San Francisco
San Francisco, CA 

Matthew Golden, MD, MPH
Professor of Medicine
Director, PHSKC HIV/STD Program
University of Washington Harborview
Medical Center
Seattle, WA 

Timothy McCajor Hall, MD, PhD
Assistant Clinical Professor
Department of Family Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA 

Turner Overton, MD
Associate Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL 

Paul Sax, MD
Clinical Director, Division of Infectious Diseases
Professor of Medicine
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA 

Hyman Scott, MD, MPH
Medical Director, Clinical Research
San Francisco Department of Public Health
San Francisco, CA 

Program Agenda

Program Agenda

Morning
8:00 Registration and Continental Breakfast 
8:30 Greeting
Judith S. Currier, MD
8:45 Advances in Antiretroviral Therapy: Can Great Get Even Better?
Paul Sax, MD
9:15 Questions & Answers
9:30 Moving Beyond "At-Risk": Getting Pre-Exposure Prophylaxis to Those Who Need It
Hyman Scott, MD, MPH
10:00 Questions & Answers 
10:15 Break
10:30 HIV Remission: Is It Desirable and How Might It Be Achieved?
Steven Deeks, MD
11:00 Questions & Answers 
11:15 STI Care in the Era of TasP AND PrEP
Matthew Golden, MD, MPH
11:45 Questions & Answers 
12:00 Lunch
Afternoon
1:00 Who Knew? The Nexus of HIV and Cardiovascular Disease
Turner Overton, MD
1:30 Questions & Answers 
1:45 Psychiatric Considerations in HIV Medicine
Timothy McCajor Hall, MD, PhD
2:15 Questions & Answers 
2:30 Treatment, Prevention and Beyond: Case-Based Discussion
Moderator: Eric S. Daar, MD
Panel: Kara Chew, MD, MS
Judith S. Currier, MD
Steven Deeks, MD
3:30 Questions & Answers 
3:45 Closing
Judith S. Currier, MD

Objectives

At the conclusion of the course attendees should be able to:

  • Identify the roles that viral fitness, viral load and host immunity play in the management of extensively pretreated patients.
  • Identify the clinical utility of genotypic and phenotypic resistance assays, and incorporate the data derived from such assays into their decision-making process.
  • Utilize the full range of therapeutic options, including newly approved and investigational drugs, for patients who have failed one or more multidrug antiretroviral regimens.
  • Treat some of the long-term complications of chronic HIV infection. 

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Miscellaneous

Conference Location

Center for Health Communication
The California Endowment
1000 N. Alameda St.
Los Angeles, CA 90012

Parking

  • Free parking available. 

 

About the Center for Clinical AIDS Research and Education

UCLA has been a leader in AIDS and HIV-related research, education and patient care since 1981 when the nation’s first cases of AIDS were identified at the UCLA Medical Center. The UCLA Center for Clinical AIDS Research and Education (CARE Center) was established in 1990 to facilitate clinical research and to integrate current research findings with teaching and patient care.

The UCLA CARE Center manages an outpatient clinic dedicated to patients with HIV and maintains an active clinical research program, which evaluates new antiretroviral therapies and investigates diseases associated with HIV and the complications of therapy. It is one of the original sites of the Adult AIDS Clinical Trials Group (ACTG) and the AIDS Malignancy Consortium (AMC). An education and outreach program disseminates information on AIDS and HIV infection to healthcare providers and to the community.

The CARE Center is also a primary location for training of medical students and housestaff at the David Geffen School of Medicine at UCLA in the optimal care of patients with HIV.

The UCLA CARE Clinic location:

1399 S. Roxbury Drive, Suite 100
Los Angeles, California 90035
(310) 557-2273

Our administrative offices are located at:

11075 Santa Monica Blvd., Suite 100
Los Angeles, California 90025
(310) 825-6689

For additional information please visit our website http://www.uclahealth.org/carecenter or CAREoutreach@mednet.ucla.edu